Idorsia Ltd (19T.SG)
| Previous close | 19.80 |
| Open | 17.78 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 17.78 - 18.42 |
| 52-week range | 17.78 - 19.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireNew Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023
Allschwil, Switzerland – November 3, 2023 Idorsia Ltd (SIX: IDIA) announced today that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist for the treatment of patients with resistant hypertension, were presented as an oral presentation entitled “Effects of aprocitentan on blood pressure lowering and proteinuria in patients with chronic kidney disease and resistant hypertension” by George Bakris, MD, at the American Society of Nephrology (ASN) Kidney Week
- GlobeNewswire
Idorsia announces financial results for the first nine months of 2023 – adapting the company to create sustainable value
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 24, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first nine months of 2023. Business highlights Transaction with Sosei Heptares (hereafter referred as the “Sosei Deal”): Idorsia sold its Asia Pacific (ex-China) operations on July 20 – including selected license rights to products – for a total consideration of CHF 400 million.Cost reduction initiative targeting a reduction of the fixed cost
- GlobeNewswire
Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023
Allschwil, Switzerland – October 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that it is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023, a global scientific congress bringing the best of sleep medicine and research to Rio de Janeiro, Brazil, October 20-25. An Industry Symposium entitled "Managing chronic insomnia disorder – what have we learned from clinical trials and real-world practice?" will be hosted by Idorsia on Tuesday, October
